التفاصيل البيبلوغرافية
العنوان: |
Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells. |
المؤلفون: |
Ravish, Akshay, Narasimhachar, Bhanuprakash C., Xi, Zhang, Vishwanath, Divakar, Mohan, Arunkumar, Gaonkar, Santosh L., Chandrashekara, Paduvalahippe Gowdegowda, Ahn, Kwang Seok, Pandey, Vijay, Lobie, Peter E., Basappa, Basappa |
المصدر: |
Biomedicines; Oct2023, Vol. 11 Issue 10, p2716, 18p |
مصطلحات موضوعية: |
PIPERAZINE, CANCER cells, NF-kappa B, PYRIMIDINES, BREAST cancer, MOLECULAR docking |
مستخلص: |
Nuclear factor kappa B (NF–κB) is a potential therapeutic target in breast cancer. In the current study, a new class of oxazine– and piperazine–linked pyrimidines was developed as inhibitors of NF–κB, overcoming the complexity of the oxazine structure found in nature and enabling synthesis under laboratory conditions. Among the series of synthesized and tested oxazine–pyrimidine and piperazine–pyrimidine derivatives, compounds 3a and 5b inhibited breast cancer cell (MCF–7) viability with an IC50 value of 9.17 and 6.29 µM, respectively. In silico docking studies showed that the pyrimidine ring of 3a and the 4–methoxybenzyl thiol group of 5b could strongly bind the p65 subunit of NF–κB, with the binding energies −9.32 and −7.32 kcal mol−1. Furthermore, compounds 3a and 5b inhibited NF–κB in MCF–7 breast cancer cells. In conclusion, we herein report newer structures that target NF–κB in BC cells. [ABSTRACT FROM AUTHOR] |
|
Copyright of Biomedicines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |